PeptideStack
5.2kquestions
20kanswers
220users

Does deamidation produce a resolvable peak on a wide-pore C18 column, or does it co-elute?

Asked 4 Apr 2026Modified 3 days agoViewed 7k times
16

The specifics, since they change the answer: deamidation · a wide-pore C18 column.

I would like the mechanism, because I want to be able to reason about the cases nobody has written about.

I have tried to reason it out from first principles and got to two contradictory conclusions.

So what is the mechanism, and how well established is it?

hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
shareeditfollowflag
NN
askednine_point_nine45k1384 Apr 2026

5 Answers

Accepted answer first, then by votes
23

Accepted answer

Gradient design is usually described as though it is a minor technical detail rather than the primary determinant of what the method measures.

System suitability checks on replicate injections of a known standard establish whether the method was in control — if the peak area varies by more than two per cent between replicates, something is wrong.

Stated carefully, formic acid is the compromise when you need the mass spectrometer on the same run, but the peak shape penalty is real and easily a tenth of a per cent on purity.

Inter-laboratory studies using identical methods on identical material show precision well within half a per cent when the method is locked down, pointing to method variability as the primary source of disagreement.

I would caution against over-interpreting small differences between runs, because the noise floor of the method is larger than most people assume.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

shareimprove this answerflag
VI
answered · acceptedvialroom87k14819 Jun 2026
8The placebo-arm figure is the part everyone omits. – kelvin_lam 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
9

More usefully, start by understanding what the detector is measuring and what that means about how the molecule needs to be prepared and handled before injection.

Acetonitrile is the organic modifier of choice because it has a good UV cutoff, a reasonable viscosity and a refractive index that minimises baseline noise.

Trifluoroacetic acid at 0.1 per cent is the standard ion-pairing agent because it suppresses tailing by neutralising the basic residues, but it also suppresses mass spectrometry signal.

The selectivity of a reverse-phase separation depends on the hydrophobicity of the side-chain profile, which is why two peptides can co-elute even if they differ by a residue.

Worth noting that the achievable resolution depends on the chemistry of the molecule — some peptide sequences separate easily while others are notoriously difficult regardless of method.

Ask for the chromatogram and the system suitability data, not just the number.

shareimprove this answerflag
DH
answeredDr_Wren_Halliday40k3811 Apr 2026
For what it is worth, my own result was within half a per cent of this. – Dr_Ingrid_Baumgartner 9 months ago
8Any reason this would differ for a longer peptide? – Dr_Rosalind_Achebe 7 months ago
add a comment
5

Specifically, high-performance liquid chromatography is a separation technique, not an identification technique, and it answers the question "how much of the detected signal is a single species" not "which species is it."

Proline-rich sequences are particularly problematic because the isomerisation kinetics are in the same timescale as the separation, leading to split or broadened peaks at low temperature.

On the detail: mobile phase pH at the point where you inject must match the mobile phase pH at the start of the gradient, or the sample will not be focused at the column head.

One qualification: the limit of detection on a reversed-phase HPLC is set by the noise on the baseline, which for these molecules is usually in the range of a tenth of one per cent or less, and anything smaller is not reproducibly detectable.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.

edited 29 Jun 2026 by k_szabo — removed a claim I could not source

shareimprove this answerflag
KS
answeredk_szabo45k3830 May 2026
5

To be exact about it, the chemistry of peptides at low pH and high organic-solvent concentration is not something most users have intuition for, which is why published methods exist.

Sample preparation is almost always under-appreciated — a reconstituted peptide in strong solvent will distort its own peak on the gradient.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

shareimprove this answerflag
TM
answeredtwo_two_micron15k1718 Jul 2026
-3

Worth being precise here: coupling the chromatography to mass spectrometry adds identity information but trades chromatographic quality for ionisation efficiency.

Detector linearity is why a heavily loaded peak can give false purity by compressing the main peak height while leaving impurity shoulders unchanged.

Peptide impurities from solid-phase synthesis include deletion sequences, truncations from premature cleavage, racemised residues from epimerisation and oxidised variants, each of which may have different chromatographic behaviour.

Ask for the chromatogram and the system suitability data, not just the number.

shareimprove this answerflag
RO
answeredrae_oyelowo21k3827 Jul 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.